Cargando…
Rational design and crystallographic analysis of novel isoform-selective TRKA inhibitors for cancer therapy
Autores principales: | Wang, Guan, Wu, Yongya, Wu, Chengyong, Shuai, Wen, Jiang, Tingting, Wang, Aoxue, Bu, Faqian, Sun, Qiu, Ouyang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939310/ https://www.ncbi.nlm.nih.gov/pubmed/36815052 http://dx.doi.org/10.1016/j.apsb.2022.10.012 |
Ejemplares similares
-
Development of small molecule extracellular signal-regulated kinases (ERKs) inhibitors for cancer therapy
por: Pan, Xiaoli, et al.
Publicado: (2022) -
A Rationale for Drug Design Provided by Co-Crystal Structure of IC261 in Complex with Tubulin
por: Xian, Jinghong, et al.
Publicado: (2021) -
TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023) -
Rational design of hydrogels for immunomodulation
por: Bu, Wenhuan, et al.
Publicado: (2022) -
Novel transcripts reveal a complex structure of the human TRKA gene and imply the presence of multiple protein isoforms
por: Luberg, Kristi, et al.
Publicado: (2015)